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Abstract—This study investigated long-term use of custom-
made orthopedic shoes (OS) at 1.5 years follow-up. In addi-
tion, the association between short-term outcomes and long-
term use was studied. Patients from a previously published 
study who did use their first-ever pair of OS 3 months after 
delivery received another questionnaire after 1.5 years. 
Patients with different pathologies were included in the study 
(n = 269, response = 86%). Mean age was 63 ± 14 years, and 
38% were male. After 1.5 years, 87% of the patients still used 
their OS (78% frequently [4–7 days/week] and 90% occasion-
ally [1–3 days/week]) and 13% of the patients had ceased using 
their OS. Patients who were using their OS frequently after 
1.5 years had significantly higher scores for 8 of 10 short-term 
usability outcomes (p-values ranged from <0.001 to 0.046). 
The largest differences between users and nonusers were found 
for scores on the short-term outcomes of OS fit and communi-
cation with the medical specialist and shoe technician (effect 
size range = 0.16 to 0.46). We conclude that patients with 
worse short-term usability outcomes for their OS are more 
likely to use their OS only occasionally or not at all at long-
term follow-up.
Key w ords: foot disorders, long-term use, medical devices, 
orthopedic shoes, orthotics, patient satisfaction, rehabilitation, 
shoes, usability, usability outcomes.
INTRODUCTION
Custom-made orthopedic shoes (OS) are prescribed 
to a wide variety of patients to prevent or diminish foot 
and/or ankle problems or to improve gait [1]. OS are fre-
quently prescribed in, for example, England and Wales 
(200,000 pairs prescribed in 2000; 52 million inhabitants) 
[2] and the Netherlands (50,000 pairs prescribed in 2006; 
16 million inhabitants) [3]. For OS to be effective and 
maximize the positive health benefits, it is essential that 
they are actually used.
Recently, we found that most OS are used shortly 
after delivery [4]. However, short-term use of an assistive 
technology (AT) does not necessarily lead to long-term 
use [5–6]. After an introductory period, patients have to 
accept the need for the AT and conclude that it will be 
useful to them in the future in order to continue their use 
of it [5–6]. Studying AT use from a longitudinal perspec-
tive is valuable as it allows one to look beyond short-term 
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studies have been published in which the continuation of 
short-term use into long-term use has been examined.
A conceptual framework for AT in general has been 
developed, proposing that long-term use depends on 
short-term outcomes [5]. For OS, short-term usability out-
comes are associated with short-term use. For example, 
more benefits of OS with regard to walking capacities, 
wound healing, and pain reduction; more comfort and 
ease of use of OS; and a more positive opinion on the cos-
metic appearance of the OS have all been associated with 
higher levels of use [4,8–11]. Whether these short-term 
outcomes are associated with long-term use as well is not 
known.
The present study is a follow-up of a previously pub-
lished study in which short-term use (3 months after 
delivery of a patient’s first pair of OS) was investigated 
[4]. The first aim of the present study was to investigate 
the long-term use of OS 1.5 years after delivery of a 
patient’s first pair. The second aim was to determine the 
association between short-term usability outcomes and 
long-term use of OS.
METHODS
Procedures
A shortened version of the Monitor Orthopedic Shoes 
(MOS) [12] was sent as a follow-up measurement to 
patients from a previously published study [4] 1.5 years 
after delivery of their first-ever pair of OS. If patients did 
not respond within 1 month, the questionnaire was sent 
again as a reminder.
Patients
In a previously published study, 339 patients of 
12 different Dutch orthopedic shoe companies who were 
provided with OS were included [4]. Inclusion criteria 
were (1) first-ever pair of OS, (2) 16 years of age or older, 
(3) able to read Dutch, and (4) able to complete the ques-
tionnaire without help related to cognitive or physical 
impairments. The 21 patients who did not use their OS 
after 3 months were excluded from analysis in this study, 
although a questionnaire was sent to them to ask if they 
were still not using their OS. Seven more patients were 
excluded: six patients had died and one patient had had a 
bilateral amputation.
Of the 311 eligible patients, 269 completed the short-
ened MOS after 1.5 years (response rate = 86%). Mean age 
of the patients included in this study was 63 ± 14 years, 
and 38 percent were male. Of these patients, 63 had diabe-
tes mellitus, 46 rheumatoid arthritis, 196 an unspecified 
foot disorder, 17 a muscular disease, and 86 another disor-
der (e.g., cerebral vascular accident, spinal cord injury, 
psoriasis, leather allergy). Disorders were indicated by 
patients themselves, and it was possible to indicate more 
than one disorder. Age, sex, and disorders of the patients 
included in the study were comparable with the nonre-
sponders. Reasons for nonresponse were not known.
Outcome Measures
The extended version of the MOS is a practical and 
reproducible questionnaire that can be used for a wide 
range of patients with foot problems [12]. However, most 
of the questions on the extended version were not relevant 
for this research. We therefore used a shortened version of 
the MOS. This version consisted of four questions 
(Appendix, available online only). Two questions regard-
ing the frequency and daily duration of use of OS were 
identical to questions in the extended version of the MOS. 
One question regarding the number of pairs of OS a 
patient was provided was added. For patients who did not 
use their OS, one question was added to ask for the reason 
of nonuse. Patients were given space for other remarks.
We defined three categories of OS use: frequent use 
(4–7 days/week), occasional use (1–3 days/week), and 
nonuse (not using OS). Nonuse was divided into two cate-
gories: nonuse due to dissatisfaction with aspects of the 
usability of the OS and nonuse due to physical changes 
that have made using OS not possible or necessary any-
more. Even though nonuse due to physical changes might 
be related to the usability of the OS, it is not always possi-
ble or reliable to interpret it as such. More important, it 
has been stressed that these are two different kinds of non-
use [13–14]. For analyses, we included only patients who 
did not use their OS because of dissatisfaction with 
aspects of the usability.
Scores for short-term (after 3 months) usability out-
comes for a patient’s first-ever pair of OS from our previ-
ous study were used [4]. Usability is “the extent to which 
a product can be used by specified users to achieve speci-
fied goals with effectiveness, efficiency, and satisfaction, 
in a specified context of use” (International Organization 
for Standardization, 9241-11). Within these domains, the 
following aspects were measured: change in walking 
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sprains (domain effectiveness); donning and doffing OS, 
fit of OS, ease of walking with OS, and weight of OS 
(domain efficiency); and cosmetic appearance of OS and 
communication with the medical specialist and the shoe 
technician (domain satisfaction).
Statistical Analysis
We assessed differences between the three groups 
with a Kruskal-Wallis test or chi-square test. The first 
was used because of nonnormal distribution of the data. 
We performed post hoc analyses to assess differences 
between the groups separately. We used a Mann-Whitney 
U-test for scale measures with a nonnormal distribution 
of the data and calculated the effect size with the follow-
ing formula: effect size = Z/(n1 + n2) [15]. We analyzed 
data using SPSS for Windows, version 16.0 (SPSS Inc; 
Chicago, Illinois).
RESULTS
Of the patients who used their OS after 3 months, 
87 percent (n = 234) used their OS at the 1.5-year follow-
up as well (78% [n = 211] frequently [4–7 days/week] and 
9% [n = 23] occasionally [1–3 days/week]) and 13 percent 
(n = 35) ceased using their OS; 57 percent (n = 20) of this 
nonuse was due to dissatisfaction with the OS (Table 1 ). 
The patients who used their OS frequently had a signifi-
cantly longer daily duration of use than the patients who 
used their OS occasionally; significantly more men than 
women frequently used their OS (Table 1).
The continuation of short-term use into long-term use 
is shown in Table 2 . Of the patients who frequently used 
their OS after 3 months, 84 percent continued to do so after 
1.5 years. In contrast, only 23 percent of the patients who 
used their OS occasionally after 3 months continued to do 
so; 46 percent of these patients used their OS frequently 
after 1.5 years, whereas 26 percent of these patients ceased 
using their OS because of dissatisfaction with the usability 
(Table 2). Three of the fifteen responding patients who did 
not use their OS after 3 months used their OS frequently 
after 1.5 years (results not shown in Table 2). These three 
patients indicated in their open answers that they continued 
trying, after discarding their first pair, until the usability of 
their second pair was satisfactory.
The scores for 8 of 10 short-term usability outcomes 
for the OS were significantly higher for patients who 
were using their OS frequently at the 1.5-year follow-up 
(Table 3 ). The largest differences between patients who 
used their OS (both frequently and occasionally) and those 
who ceased using their OS were found for scores of fit of 
OS and communication with both the medical specialist 
and the shoe technician (post hoc analyses; Table 3 ). The 
largest differences between patients who frequently and 
those who occasionally used their OS were found for 
scores on change in pain, weight of the OS, and cosmetic 
appearance of the OS (post hoc analyses; Table 3).
DISCUSSION
In the present long-term follow-up study, we found 
that 87 percent of the patients who used their OS at short 
term still used their OS after 1.5 years and 13 percent of 
the patients ceased using their OS. Of this nonuse after 
1.5 years, 57 percent was due to dissatisfaction with the 
usability of the OS. We further found that high scores for 
8 of 10 short-term usability outcomes were significantly 
associated with long-term use. Patients who ceased using 
their OS after 1.5 years had the lowest scores for short-
term outcomes concerning the fit of their OS and commu-
nication with both the medical specialist and shoe techni-
cian. Patients who used their OS only occasionally after 
1.5 years had, in comparison with those who used their 
OS frequently after 1.5 years, significantly lower scores 
for short-term outcomes concerning change in pain, 
weight of the OS, and cosmetic appearance of the OS.
This is the first study in which long-term follow-up of 
OS use was investigated. The rates of long-term use found 
support the conclusion that nonuse of OS is not a major 
problem in the Netherlands, neither at short nor at long 
term [4,16]. However, not all patients continued to use 
their OS, which indicates room for improvement. More 
than half of the patients who ceased using their OS did so 
because of dissatisfaction with aspects of the usability of 
their OS. This dissatisfaction was indicated at long-term 
follow-up; however, it could also be seen in lower scores 
for short-term usability outcomes. This association between 
short-term outcomes and long-term use is in line with a 
conceptual model for AT in general [5].
In order to discuss the clinical implications of these 
findings, we must discuss some limitations of this study 
first. The scores for short-term outcomes that were used in 
this study were for a patient’s first pair of OS only. After 
1.5 years, patients have usually been provided with a 
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patient’s second or third pair may be different, yet this dif-
ference was not taken into account. All OS are fully cus-
tom-made, and even though the same individual model cast 
is used, variation between the pairs is always possible. This 
could, for example, be seen in the three patients who dis-
carded their first pair, yet are now using their subsequent 
pair frequently. The usability of the pair(s) of OS a patient 
is currently using might be more important than the short-
term outcomes of a previous pair. However, we still found a 
strong association between the usability of the first pair and 
use at follow-up. This might imply that the first experiences 
a patient has with OS are important with regard to the use 
of future pairs.
Table 1.
Patient characteristics, categorized with regard to frequency of use of their custom-made orthopedic shoes (OS) 1.5 years after delivery. Values 
are % (n) or otherwise indicated. Frequent use = using OS 4–7 days/week, occasional use = using OS 1–3 days/week, nonuse = not using OS.
Characteristic
Frequent Use
(78%; n = 211)
Occasional Use
(9%; n = 23)
Nonuse
(13%; n = 35) p-Value
*
Sex
Male 42 (89) 13 (3) 31 (11) 0.02
Female 58 (122) 87 (20) 69 (24)
Age (years)† (mean ± SD) 64 ± 14 64 ± 14 59 ± 17 0.20
Main Reason‡
Pain 54 (114) 74 (17) 63 (22) NA
Wounds 9 (19) 4 (1) 6 (2)
Foot Deviation 24 (51) 4 (1) 20 (7)
Leg Length Difference 2 (4) 4 (1) 0 (0)
Other 11 (23) 13 (3) 11 (4)
Pairs of OS Provided
One 5 (11) 30 (7) 54 (19) NA§
Two 66 (140) 57 (13) 26 (9)
Three 23 (48) 13 (3) 6 (2)
Four 5 (10) 0 (0) 0 (0)
Five 1 (2) 0 (0) 0 (0)
Missing 0 (0) 0 (0) 14 (5)
Daily Duration of Use (hours/day)
>12 39 (81) 4 (1) — <0.001
8–12 31 (66) 9 (2) —
4–8 22 (47) 26 (6) —
1–4 8 (17) 61 (14) —
<1 0 (0) 0 (0) —
Reason for Nonuse
Dissatisfaction with Usability 
Effectiveness — — 17 (6) NA
Comfort — — 40 (14)
Physical Changes¶
Positive — — 17 (6) NA
Negative — — 23 (8)
Missing — — 3 (1) NA
Note: Percentages may not add to 100 because of rounding. 
*p-Value for differences between frequent users, occasional users, and nonusers is shown.
†Age at moment of first measurement, i.e., 3 months before delivery of patient’s first pair of OS.
‡Main reason was indicated by patients themselves.
§Chi-square test was not applicable because more than 25% of cells had expected count <5.
¶Positive changes mean that patients do not need their OS anymore; negative changes mean that patients were not able to use their OS anymore.
NA = not applicable, SD = standard deviation.
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Continuation of short-term use into long-term use. Values are % (n). Short-term use = use after 3 months, long-term use = use after 1.5 years, fre-
quent use = using OS 4–7 days/week, occasional use = using OS 1–3 days/week, nonuse = not using OS.
Short-Term Use
Long-Term Use
Total†
Frequent Use Occasional Use
Nonuse*†
Dissatisfied Physical
Frequent Use 84 (195) 6 (15) 5 (11) 5 (12) 100 (233)
Occasional Use 46 (16) 23 (8) 26 (9) 6 (2) 100 (35)
Note: Percentages are shown within short-term use. Percentages may not add up to 100 because of rounding.
*Nonuse could be due to dissatisfaction with aspects of usability or to physical changes that have made using OS not possible or necessary anymore.
†One patient is missing because reason for nonuse was not known.
OS = custom-made orthopedic shoes.
Table 3.
Association between long-term use of OS and short-term outcomes of aspects of usability. Values are median (interquartile range) or % (n) or as 
indicated.
Outcome
Freq
(78%; n = 211)
Occ 
(9%; n = 23)
Non*
(7%; n = 20) p-Value
†
Post Hoc Analyses
Freq–Non Freq–Occ Occ–Non
p-Value‡ ES p-Value ‡ ES p-Value ‡ ES
Effectiveness
Change in Pain (skin)§
(n = 128; 14; 12)¶
86 (65.25–95) 61 (43.25–88.75) 53 (50.25–70) 0.007 0.01 0.21 0.01 0.19 0.88 0.04
Change in Pain (muscles)§
(n = 121; 19; 17)¶
92 (64–93) 59 (42–75) 71 (50.5–84) 0.001 0.06 0.14 0.001 0.25 0.23 0.20
Change in Sprains§ 91 (76.5–97) 95 (78–98) 83 (55–98) 0.49 0.62 0.05 0.28 0.10 0.37 0.19
Efficiency
Donning/Doffing OS§ 75 (51–89) 74 (40–85) 51 (28–93) 0.29 0.24 0.08 0.26 0.07 0.94 0.01
Fit of OS§ 86 (71–94.75) 85.5 (69.5–94.5) 39 (16.75–77.75) <0.001 <0.001 0.27 0.99 0.00 0.003 0.46
Ease of Walking with OS§ 83 (66–93) 65.5 (43.75–89.75) 48.5 (18.75–83.25) <0.001 <0.001 0.25 0.23 0.15 0.13 0.24
Weight of OS§ 48 (27–53) 27 (18–48) 49 (23–52) 0.03 0.82 0.01 0.007 0.18 0.09 0.27
Satisfaction
Cosmetic Appearance:
Patient’s Opinion§
61.5 (47–81) 49 (18–69) 51 (23–76) 0.02 0.17 0.09 0.007 0.18 0.52 0.10
Cosmetic Appearance:
Other’s Opinion
Very Ugly or Ugly 7 (14) 22 (5) 10 (2) NA** — — — — — —
Neutral 39 (83) 35 (8) 45 (9) — — — — — —
Attractive or Very Attractive 40 (85) 30 (7) 25 (5) — — — — — —
Do Not Know or Missing 14 (29) 13 (3) 20 (4) — — — — — —
Communication with Medical 
Specialist§
85 (66.5–93.75) 87 (62–95) 68 (51.75–73.75) 0.01 0.002 0.22 0.94 0.01 0.08 0.29
Communication with Shoe 
Technician§
87 (73–94) 85 (75–96) 68 (49.25–90) 0.046 0.01 0.16 0.86 0.01 0.048 0.30
Note: Percentages many not add to 100 because of rounding.
*Only patients who did not use their OS anymore and were dissatisfied with usability of their OS were taken into account; patients who did not use their OS because 
of physical changes (n = 14; 5%) or for whom a reason for no use was missing (n = 1) were not taken into account.
†p-Value for difference between three groups is shown.
‡p-Value for difference between two groups is shown.
§Scores could range from 0 (most negative score possible) to 100 (most positive score possible).
¶Not all patients had wounds, pain, or sprains; therefore, number of patients for these questions is indicated for each group respectively.
**Chi-square test was not applicable because more than 25% of cells had expected count <5.
ES = effect size, Freq = frequent use (using OS 4–7 days/week), NA = not applicable, Non = nonuse (not using OS), Occ = occasional use (using OS 1–3 days/
week), OS = custom-made orthopedic shoes.
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patients over the three groups. A large majority of 
patients used their OS frequently, whereas only a small 
percentage used them occasionally or not at all. This is 
clearly a positive result from a clinical point of view. 
However, the comparison between the groups might be 
affected by the skewed distribution. Because the differ-
ences between the groups were rather large, in our opin-
ion this effect will be small. Further, it was not possible 
to perform multivariate analyses or to calculate odds 
ratios. A larger group of patients should be studied to 
overcome these problems.
This study has two important clinical implications. 
The association found between short-term outcomes and 
long-term use implies that it is important to monitor 
patients for longer periods. All patients in this study were 
using their OS after 3 months; however, for some patients 
this short-term use did not continue into long-term use. 
Patients with worse short-term outcomes are more likely 
to use their OS less or not at all after 1.5 years follow-up. 
Patients who are not satisfied with aspects of the usability 
of their OS should be monitored closely to prevent them 
from using their OS less or not at all after the first few 
months. Attention needs to be paid to these patients in 
clinical practice.
Patients who ceased using their OS gave communica-
tion with both the medical specialist and the shoe techni-
cian significantly lower scores. This again stresses the 
importance of this communication in relation to the 
actual use of OS [14,17–19]. It can be hypothesized that 
patients who are dissatisfied with the communication are 
less willing to return to the medical specialist or shoe 
technician in order to change their OS when they do not 
fit perfectly. These patients are probably more likely to 
stay at home and stop using their OS. Further research 
into the intricacies of the communication between 
patient, medical specialist, and shoe technician is needed. 
In clinical practice, attention should be paid to patients 
who are dissatisfied with the communication to prevent 
them from not using their OS long-term.
CONCLUSIONS
We conclude that a large majority of patients is still 
using their OS at long-term follow-up. This long-term 
use is associated with positive short-term usability out-
comes for a patient’s OS; patients with worse short-term 
usability outcomes for their OS are more likely to use OS 
only occasionally or not at all at long-term follow-up. 
This implies that these patients should be monitored 
closely, even when OS are used in the short term. The 
large differences found between users and nonusers for 
communication with the medical specialist and shoe 
technician again stresses the importance of this commu-
nication in relation to the use of OS.
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